Correlation Between Pliant Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Pliant Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Pliant Therapeutics and Milestone Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pliant and Milestone is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 1.83 times less return on investment than Milestone Pharmaceuticals. In addition to that, Pliant Therapeutics is 1.39 times more volatile than Milestone Pharmaceuticals. It trades about 0.05 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.14 per unit of volatility. If you would invest 146.00 in Milestone Pharmaceuticals on September 5, 2024 and sell it today you would earn a total of 39.00 from holding Milestone Pharmaceuticals or generate 26.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Pliant Therapeutics |
| Milestone Pharmaceuticals |
Pliant Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Pliant Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |